Covaxis

Covaxis is a combination vaccine designed to protect against diphtheria, tetanus, pertussis, and haemophilus influenzae type b. It is commonly administered to children for comprehensive immunization.

Covaxis is primarily used to prevent serious bacterial and viral infections. This vaccine is typically administered to infants and young children to build immunity against diphtheria, tetanus, pertussis, and haemophilus influenzae type b. It is often recommended as part of routine childhood vaccination schedules to ensure long-term protection against these potentially life-threatening diseases.

Common effects of Covaxis may include mild redness, swelling, or tenderness at the injection site. Some individuals might experience low-grade fever, irritability, or loss of appetite following vaccination. These effects are generally mild and temporary, resolving within a few days.

Covaxis should be administered by a healthcare professional. It is important to inform the healthcare provider about any allergies or previous adverse reactions to vaccines. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. Always follow the recommended storage and handling guidelines to maintain the vaccine's efficacy.

Covaxis may interact with other medications or vaccines. It is advisable to discuss any ongoing treatments or recent vaccinations with a healthcare provider before administration. Certain medications, such as immunosuppressants, may affect the vaccine's effectiveness. Always consult a healthcare professional for personalized advice.